Private Equity Isn’t Collapsing. Its Easiest Money May Be Gone
For years, private equity was sold to institutional investors as something close to a financial upgrade over the public markets. Investors would accept years of illiquidity, expensive management fees and limited visibility in exchange for access to skilled managers who could buy companies, improve them and eventually sell them at substantial gains. Pension funds, endowments and wealthy investors poured money into the strategy, helping private markets grow from a specialist corner of finance into an enormous industry with trillions of dollars under management.
That model has not collapsed, and the latest deal data make that clear. Global private-equity investment reached roughly $2.1 trillion in 2025, a four-year high, while McKinsey reported that large buyout and growth transactions exceeded $1 trillion for the first time. What has changed is the economic environment that made private equity unusually forgiving. Cheap debt, expanding valuation multiples and abundant buyers once allowed firms to generate strong returns even when operational improvements were modest. Today, higher financing costs, aging portfolio companies, slower distributions and intense competition mean managers increasingly have to produce genuine business improvement rather than relying on favorable financial conditions.
For investors, that distinction matters. Private equity may remain a valuable part of a sophisticated portfolio, particularly with exceptional managers, but the assumption that simply moving money out of public stocks and into private funds automatically produces higher, steadier returns is becoming harder to defend.
The Industry Became a Victim of Its Own Success
Private equity’s early advantage came partly from scarcity. There were fewer firms competing for acquisitions, less institutional capital chasing deals and greater opportunity to purchase companies at attractive prices. As returns attracted more investors, those advantages began eroding because successful strategies rarely remain uncrowded for long.
The growth has been extraordinary. McKinsey’s data show global private-equity assets increasing dramatically since the beginning of the century, while U.S. private-equity firms alone had roughly $3.13 trillion under management by September 2024. European private equity and venture capital have also continued expanding, with capital under management reaching €1.37 trillion in 2025, 2.7 times the level of a decade earlier. The exact percentage increase depends on which strategies and regions are included, so a blanket claim that the industry expanded precisely 1,400% since 2000 should be treated cautiously, but the underlying point is undeniable: far more capital is competing for private assets than two decades ago.
That competition changes the price of everything. When several private-equity firms bid for the same company, the acquisition multiple rises and more of the future return has already been paid to the seller at closing. Managers can compensate by growing revenue, improving margins or making better strategic decisions, but the hurdle becomes increasingly difficult. The industry expanded because the historical returns were attractive, and that expansion itself made attractive returns harder to reproduce.
Recent Returns Have Challenged the Idea That Private Is Automatically Better
Private equity still has a respectable long-term track record, particularly over periods of 10 years or more. Cambridge Associates reported that U.S. private equity has more consistently outperformed public-market benchmarks over longer periods, while its results versus large-cap public stocks have been mixed over the most recent five years. The distinction matters because critics sometimes overstate the case by claiming private equity has simply failed to beat the S&P 500.
Recent performance has nevertheless been much less impressive. Cambridge Associates reported that its U.S. Private Equity Index returned 8.7% in 2025, with buyouts returning 7.6%, while public markets outperformed private equity across most periods shorter than 10 years. That comparison becomes more uncomfortable when investors remember what they give up to own private equity: ready access to their money, daily price transparency and the simplicity of low-cost publicly traded index funds.
Private-equity investors should logically demand a premium for those disadvantages. Locking money away for a decade only to receive approximately the same return available from liquid public stocks is not an obviously attractive bargain. The challenge for the industry is therefore not merely producing positive returns but delivering enough excess return to compensate investors for illiquidity, complexity, fees and manager-selection risk.
Private Valuations Look Smoother Partly Because They Are Not Updated Every Second
One of private equity’s most attractive characteristics can also be one of its most misleading. Public stocks are repriced constantly, which means every recession, interest-rate shock and disappointing earnings report immediately appears in the portfolio. Private companies are valued periodically using models, comparable transactions and manager judgment, which can make reported returns look significantly smoother.
That does not mean managers are routinely inventing numbers. Private funds operate under accounting standards, outside audits and valuation policies, and most large institutional managers devote significant resources to determining fair value. The fundamental difficulty is that there may be no actual market transaction revealing what a private company is worth today. Until the asset is sold, recapitalized or otherwise tested in the marketplace, reported net asset value remains an estimate.
That creates the possibility of stale valuations. When public markets decline sharply, the price of a listed company can fall 20% in days while a comparable private company may still be reported close to its previous quarter’s valuation. The private asset appears less volatile, but part of that stability can reflect slower price discovery rather than lower economic risk.
This distinction has become increasingly important as private funds hold investments longer. A company purchased at a high valuation in 2021 may remain on a fund’s books years later without a clean market transaction establishing its current worth. Until the company is actually sold, investors are relying partly on the manager’s marks rather than a price established between unrelated buyers and sellers.
The Real Pressure Point Is Cash Coming Back to Investors
Institutional investors ultimately cannot spend an internal rate of return printed on a quarterly statement. They need distributions.
That is where private equity has experienced one of its most important recent problems. McKinsey reported that five-year rolling distributions relative to assets under management for buyout funds fell to their lowest recorded level in 2025. During the six months ending June 2025, distributions represented roughly 6% of assets under management, compared with a 10-year average of approximately 14%. Bain similarly described the 2025 recovery as uneven, noting that deal and exit values improved while distributions remained stubbornly low and fundraising remained difficult for many managers.
This creates a liquidity problem for pension funds, endowments and other limited partners. Private-equity funds routinely call capital when they make investments and return capital when businesses are sold. When exits slow, investors receive less money back but may still have commitments to newer funds. That can force institutions to find cash elsewhere or reduce new allocations to private markets.
It also exposes the difference between reported wealth and realized wealth. A fund can report a valuable portfolio while investors wait years to discover whether those valuations can actually be achieved in a sale. The longer the delay, the more pressure there is to turn paper gains into cash.
Higher Interest Rates Broke an Important Part of the Old Playbook
Private equity did not invent leverage, but borrowing has always been central to the modern leveraged-buyout model. A fund contributes equity, uses debt to finance a substantial portion of the acquisition and attempts to improve the company while paying down that debt. If the business eventually sells at a higher value, leverage can dramatically increase the return on the fund’s original equity.
The strategy became particularly powerful during the long era of extremely low interest rates. Debt was inexpensive, refinancing was readily available and buyers could often pay higher multiples because financing costs were so manageable. Rising valuations provided another source of return: A company purchased at 10 times earnings could produce an attractive gain if sold years later at 13 times earnings even without extraordinary operational improvement.
Those conditions have changed. Bain’s 2026 industry report describes a new environment in which cheap debt, low purchase prices and easy multiple expansion can no longer be assumed. Firms now have to produce more earnings growth to generate the same equity return because financing consumes more cash and exit valuations cannot be expected to continually rise.
That does not make the private-equity model unworkable. It makes mediocre investing less forgiving. Firms that genuinely improve businesses may still perform extremely well, while those relying primarily on leverage and financial engineering have much less room for error.
Cost Cutting Becomes Dangerous When the Company Provides Essential Care
Private equity becomes more controversial when the portfolio company is not merely selling software or industrial equipment but providing healthcare, housing or another essential service. Cutting unnecessary corporate expenses can be responsible management, but reducing staffing or service quality can create consequences that extend far beyond investment returns.
Nursing homes provide some of the strongest evidence. A peer-reviewed study published in The Review of Financial Studies found that private-equity ownership was associated with an increase in mortality among a subset of Medicare nursing-home patients, along with declines in staffing and compliance with care standards. The authors estimated an 11% increase in mortality using their instrumental-variable methodology, while emphasizing that the effects were nuanced rather than identical across every patient and facility.
A 2025 systematic review examining 12 studies of private-equity-owned nursing homes similarly found associations with reduced nursing hours, increased deficiencies, more hospital visits and higher mortality in several studies. It also concluded that financial improvements were inconsistent and that heavy debt could create longer-term financial challenges.
These findings should not be generalized into the claim that private equity inevitably causes deaths whenever it enters healthcare. Ownership structures, operators and facilities differ enormously, and researchers continue debating causal mechanisms. They do show why the usual cost-cutting playbook becomes ethically and politically complicated when labor represents patient care rather than administrative overhead.
Leverage Can Transfer Risk From the Fund to the Company
One of the most important features of a leveraged buyout is that much of the acquisition debt is generally carried by the acquired company rather than remaining solely at the private-equity fund level. That can amplify shareholder returns when the business performs well because relatively little equity controls a much larger enterprise.
The tradeoff is that the company must service the debt. Cash that might otherwise fund investment, staffing, technology or expansion can instead go toward interest payments, and the business has less room to absorb an economic downturn. A company with a conservative balance sheet can survive several weak years, while a heavily leveraged one may face restructuring after a comparatively modest decline in earnings.
The model becomes particularly aggressive when financial engineering extends beyond ordinary acquisition debt. Private-equity owners may use dividend recapitalizations to borrow additional money and distribute the proceeds to shareholders, or sell company-owned real estate and lease it back to create immediate liquidity. Those strategies can make economic sense in some circumstances, but they also transfer future obligations onto the operating company.
This is why evaluating private equity requires looking beyond whether the fund made money. Investors, employees, creditors and customers can experience very different outcomes from the same transaction.
Valuation Conflicts Become More Serious When Funds Need New Money
Private-equity managers have incentives that do not always perfectly align with those of investors. Management fees are typically based partly on committed or invested capital, while carried interest gives managers a share of investment profits. A manager also needs a strong historical track record to raise the next fund.
That does not mean firms can simply fabricate valuations without consequences, but it does create pressure around assets that have not yet been sold. A higher reported value can improve interim performance metrics and make the portfolio appear healthier, while marking an investment down forces investors to confront a loss before a final exit occurs.
The increasingly common use of continuation funds illustrates the complexity. Instead of selling an asset to an unrelated buyer, a private-equity manager may transfer it from an older fund into a newly created vehicle that allows existing investors to cash out or roll their interest forward. Continuation funds can provide legitimate liquidity and allow managers to hold promising companies longer, but they also create potential conflicts because the same manager can effectively sit on both sides of the transaction.
For investors, the most important protection is skepticism toward unrealized performance. A fund that has already returned substantial cash is different from one whose impressive return depends largely on companies that remain unsold at manager-determined valuations.
Private Equity Is Not One Asset Class With One Outcome
The phrase “private equity” can obscure enormous differences among managers. One firm may buy mature industrial companies, another invests in healthcare providers, another specializes in distressed businesses and another focuses on high-growth technology. Their use of debt, operating expertise and investment discipline can be completely different.
Performance dispersion reflects that variation. Cambridge Associates’ long-term research continues to show that private equity can outperform public markets over extended periods, which is one reason major institutional investors have not abandoned the asset class. At the same time, recent results have made manager selection increasingly important because simply owning an average private-equity fund has not consistently delivered a compelling premium over large-cap public equities.
That is a critical distinction for individual investors as private markets increasingly move beyond pension funds and university endowments. A sophisticated institution may have teams performing due diligence on hundreds of managers, negotiating fees and obtaining access to historically strong funds. A retail investor purchasing whatever private-market product happens to be offered through a brokerage platform may not receive the same opportunity set.
Private equity’s historical success therefore should not be interpreted as evidence that any investment labeled “private” is superior to a public index fund.
Regulation Is Increasing, Particularly Around Healthcare and Housing
Private equity’s growing economic footprint has inevitably attracted greater political attention. The debate increasingly focuses not merely on investor returns but on what happens when private funds own nursing homes, hospitals, physician groups, rental housing and other businesses that directly affect household well-being.
In July 2026, lawmakers reintroduced the Health Over Wealth Act, which would impose additional transparency and accountability requirements on private-equity and other for-profit ownership of healthcare providers. The proposal specifically targets hospitals, nursing homes, behavioral-health facilities and other medical businesses, reflecting concerns about how ownership structures, debt and financial arrangements affect patient care.
Housing has produced similar proposals. The Stop Wall Street Landlords Act of 2026 would restrict tax benefits for very large investors owning single-family homes and impose additional penalties intended to reduce institutional ownership, although the bill had only been introduced and referred to committees as of August 2026. Another Senate proposal would impose taxes ranging from 1% to 5% on certain investor purchases of single-family homes depending on the size of the buyer’s portfolio.
Carried interest remains another recurring target. Senators introduced legislation again in April 2026 seeking to change the favorable tax treatment available to investment managers under current law. None of these proposals means private equity is about to be regulated out of existence, but the industry’s expansion into essential services has made it much more politically exposed than when buyout firms operated largely outside public attention.
The Industry Is Recovering, Not Collapsing
Calling the current environment a private-equity collapse would ignore what actually happened in 2025. Global investment increased, large transactions returned and exit activity improved. S&P Global reported that global private-equity and venture-capital entry value rose 20% during 2025, while exits increased 5.4%. KPMG reported $1.1 trillion of U.S. private-equity investment alone, close to the extraordinary levels reached in 2021.
What has not returned is the effortless version of the old model. Bain describes the recovery as K-shaped, with stronger firms gaining traction while others struggle with aging assets, weak distributions and difficult fundraising. McKinsey similarly points to longer holding periods and historically weak distribution rates even as dealmaking recovers. Those conditions suggest consolidation rather than extinction, with capital increasingly flowing toward the managers investors believe can actually create operational value.
That may ultimately be healthy for the industry. When almost every fund can raise money and leverage produces easy returns, discipline deteriorates. A tougher market forces firms to justify their fees, demonstrate operating skill and sell investments at prices another buyer is willing to pay.
Investors Should Focus on Cash, Not Just Reported Returns
The central question for private-equity investors is no longer whether private markets once produced strong returns. They clearly did. The more useful question is whether the expected return from a particular fund is sufficient to compensate for the additional risks being accepted today.
That requires looking beyond headline internal rates of return. Investors should examine how much capital has actually been distributed, how much performance remains unrealized, how aggressively assets are valued, how much leverage portfolio companies carry and whether returns came primarily from business growth or from buying with cheap debt and selling at a higher multiple. Fees matter as well because even a modest performance advantage can disappear if the investor pays substantially more to obtain it.
Public markets provide an unforgiving benchmark because they offer immediate liquidity, transparent pricing and extremely low-cost diversification. A private investment does not merely need to earn money; it should earn enough additional money to justify giving up those benefits. Over long periods, high-quality private-equity managers have demonstrated that ability. Over the most recent several years, the average case has been considerably less convincing.
Private equity is therefore not facing an extinction event. It is confronting something potentially more disruptive: an environment in which investors can no longer assume the label itself guarantees superior performance.
The industry grew enormous by promising investors an illiquidity premium and managers capable of creating value away from public-market scrutiny. Now it has to prove those advantages still exist when debt is more expensive, exits are harder, competition is intense and regulators are paying closer attention.
That is not the collapse of private equity. It is the end of the period when too much of private equity could succeed without being particularly exceptional.
